The Urgent Need to Intensify Vaccine Development and Manufacturing in Africa: Lessons from Emerging Pandemics
Melody Okereke
Faculty of Pharmaceutical Sciences, University of Ilorin, Kwara State, Nigeria
Habeebullah Oladipo
Faculty of Pharmaceutical Sciences, University of Ilorin, Kwara State, Nigeria; Deptartment of Microbiology, Faculty of Life sciences, University of Ilorin, Nigeria
Mercy Aransiola
Faculty of Pharmaceutical Sciences, University of Ilorin, Kwara State, Nigeria
Faridah Adebowale
Faculty of Pharmaceutical Sciences, University of Ilorin, Kwara State, Nigeria
Habib Yusuf
Faculty of Pharmaceutical Sciences, University of Ilorin, Kwara State, Nigeria
DOI: https://doi.org/10.24926/iip.v13i4.5049
Abstract
Over the years, the African continent has been severely plagued by disease outbreaks, most of which have resulted in devastating pandemics. Despite having the greatest burden and impact of these disease outbreaks, regional efforts to develop and manufacture vaccines in the continent have been inadequate, with a potential impact on pandemic preparedness and readiness efforts in the continent. Given that disease outbreaks are still likely to occur in the future, we discuss the urgent need to intensify vaccine development and manufacturing in Africa based on the lessons learnt from emerging pandemics.